Pdg110 a Buyers' Club to Improve Access to Hepatitis C and Hiv Treatment for Vulnerable Populations

Abstract

the first two years was 0.26 (0.14-0.46, p,0.001), while the HR of MI was 0.31 (0.17-0.58, p,0.001) and the HR of bleeding was 0.04 (0.01-0.33, p=0.002). The HR of MACE, MI and bleeding for the subsequent eight years, as well as the HR of all-cause mortality and cardiovascular mortality, were statistically insignificant. Conclusions: The study showed that switching of newer P2Y12 receptor inhibitors and clopidogrel in DAPT was associated with fewer MACE, fewer MI and fewer bleeding in first two years post-discharge, compared to nonswitching strategy in East Asian ACS patients. There were no statistically significant differences for MACE, MI and bleeding in the subsequent eight years, nor for allcause mortality and cardiovascular mortality.